Table 2 Clinical characteristics and CNS relapse types
Characteristics | Isolated CNS | Synchronic CNS and systemic disease | P value* |
|---|---|---|---|
N (%) | N (%) | ||
Age | |||
≤ 60 | 10 (47.6) | 3 (60.0) | 1.000 |
> 60 | 11 (52.4) | 2 (40.0) | |
Relapse time | |||
≤ 1 year | 5 (23.8) | 4 (80.0) | 0.034 |
> 1 year | 16 (76.2) | 1 (20.0) | |
Primary site | |||
Lymph node | 9 (42.9) | 3 (60.0) | 0.635 |
Extra node | 12 (57.1) | 2 (40.0) | |
Intravenous MTX | |||
Yes | 2 (9.5) | 0 (0.0) | 1.000 |
No | 19 (90.5) | 5 (100) | |
Rituximab | |||
Yes | 10 (47.6) | 1 (20.0) | 0.356 |
No | 11 (52.4) | 4 (80.0) | |